Wakunaga Pharmaceutical Co., Ltd.
10
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
10.0%
1 terminated/withdrawn out of 10 trials
90.0%
+3.5% vs industry average
10%
1 trials in Phase 3/4
22%
2 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
The Efficacy Of AGE On Periodontitis
Role: collaborator
Effects of Probiotics in Patients With Ulcerative Colitis
Role: collaborator
Probiotics on Stress-associated Gastrointestinal Function in University Students
Role: collaborator
Probiotics and Health-related Quality of Life in Individuals With Seasonal Allergies
Role: collaborator
Effect of Aged Garlic Extract on Atherosclerosis
Role: collaborator
Antioxidant Effect of Aged Garlic Extract
Role: collaborator
Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome
Role: collaborator
The Effect of Aged Garlic Extract Supplementation on Immune System
Role: collaborator
Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS)
Role: collaborator
Effects of Monascus Garlic Fermented Extract on Serum Triglyceride Level
Role: collaborator
All 10 trials loaded